Subject: MDCL Applauds the Historical Passing of the SAFE Banking Act

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MDCL Applauds the Historical Passing of the SAFE Banking Act. U.S. Cannabis Companies Now on Equal Footing with Canadian Competitors
Hot Stock to WatchHot Stock to Watch

Company: Medicine Man Technologies Inc. (OTCQX: MDCL)


Price: 3.605

Change (%): - 0.125 (3.35)

Volume: 12,715
MDCL Chart

Medicine Man Technologies Resoundingly Applauds the Historical Passing of the SAFE Banking Act by the U.S. House of Representatives

  • SAFE Banking Act would provide cannabis companies access to banking services that all other legal businesses have
  • American cannabis companies would be on more equal footing with Canadian cannabis peers with access to depository and credit services
DENVER, Sept. 26, 2019 /PRNewswire/ — Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or the “Company”) today applauded the passing of the Secure and Fair Enforcement (SAFE) Banking Act by the U.S. House of Representatives by a vote of 321-103. This proposed law would protect financial institutions that serve cannabis-related businesses from federal penalties in states where cannabis operations are legal and would allow consumers the ability to legally purchase cannabis products with other forms of payment besides cash. The bill now moves to the Senate for a potential vote in that chamber.

Currently, and if the SAFE Banking Act does not ultimately get signed into law, businesses engaged in cannabis operations are prohibited from traditional financial services offered by banks, credit unions, and insurance providers, as this is considered “money laundering” due to cannabis still being considered a controlled substance at the federal level. This means that cannabis businesses do not have access to ordinary banking services, such as checking accounts, loans, electronic funds transfer (EFT), and credit cards that other businesses and industries do.

“The passing of the SAFE Banking Act by the House is a monumental step forward for our industry, as it puts us closer to finally being on equal ground with other legal businesses in the U.S.,” commented Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies. “As an industry, we are currently being forced to operate as a cash-only business, which needlessly puts consumers and industry employees at a safety risk from incentivized crime and theft. We are happy to see the government finally recognize and address these issues. The ‘Prohibition at all costs’ way of enforcement is badly outdated and constrains our industry by placing excessive restrictions on what should be relatively routine financial transactions by us as a business as well as by our customers. Ultimately, it is hurting the American economy and the small business cannabis companies that are the heart and soul of our industry. Some of our Canadian cannabis peers enjoy appreciable advantages in this area, placing a further unnecessary burden on American cannabis companies. The SAFE Banking Act would be an absolute victory for common sense and would help American cannabis companies increase our competitiveness in the global cannabis market. We are really hopeful that the U.S. Senate will also pass the bill in the near future and excited about the prospects of banking flexibility as the industry continues to flourish.”

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks